دورية أكاديمية
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer
العنوان: | Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer |
---|---|
المؤلفون: | Vergote, Ignace, Ray-Coquard, Isabelle, Anderson, Daniel M., Cantuaria, Guilherme, Colombo, Nicoletta, Garnier-Tixidre, Claire, Gilbert, Lucy, Harter, Philipp, Hettle, Robert, Lorusso, Domenica, Mäenpää, Johanna, Marth, Christian, Matsumoto, Koji, Ouwens, Mario, Poveda, Andrés, Raspagliesi, Francesco, Rhodes, Kirsty, Rubio Pérez, María J., Shapira-Frommer, Ronnie, Shikama, Ayumi, Sikorska, Magdalena, Moore, Kathleen, DiSilvestro, Paul |
المصدر: | In European Journal of Cancer November 2021 157:415-423 |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!